Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

Background and purpose Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4....

Full description

Bibliographic Details
Main Authors: Anding Xu, Yongjun Wang, Huisheng Chen, Yi Yang, Li Yang, Huaguang Zheng, Chuanling Li, Yangkun Chen, Fu-Dong Shi, Xiaoping Cui, Zuneng Lu, Yanling Liang, Songbiao Cui, Yiqing Wu, Yaqing Sun
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/5/3/285.full

Internet

https://svn.bmj.com/content/5/3/285.full

Similar Items